IBM has partnered with OpenAI to enhance its enterprise AI solutions, aiming to improve B2B digital commerce and provide faster drug discovery. The partnership will allow IBM to leverage OpenAI’s technology, increasing its capability in AI-driven solutions for enterprises. The advancements in AI are anticipated to reduce drug discovery times significantly, impacting the pharmaceutical industry…
